All Regulation articles – Page 22
-
NewsEuropean chemicals body links titanium dioxide to cancer
Chemical found in everything from paint to toothpaste added to list of suspected carcinogens over inhalation risk
-
NewsEU regulation to curb trade in conflict minerals
Companies importing metals from countries affected by violence and exploitation will have to audit their supply chain
-
OpinionHow safe should drugs be?
What does spotting new risks in approved medicines say about how effective regulators are?
-
BusinessPollution from Indian drugmakers drives drug resistance
Areas around manufacturing sites still heavily contaminated with antimicrobials and breeding multidrug-resistant pathogens
-
NewsUK crops at risk if EU pesticide ban expanded
Agricultural research institute calls for unbiased research on pesticides linked to bee decline
-
NewsLegal battles stall US biosimilars
Unclear legislation and lack of regulatory guidance means companies are turning to the courts
-
BusinessUS Steel plant spills chromium into waterway
Pipe failure releases 135kg of hexavalent chromium into Lake Michigan tributary
-
NewsUS environment agency advisory board in turmoil
Trump administration poised to replace almost three-quarters of EPA’s scientific advisory board with more industry-friendly picks
-
NewsAction on white asbestos blocked by top exporters
Chrysotile will not be added to Rotterdam Convention’s list of hazardous substances
-
BusinessFarmers sue to block Syngenta–ChemChina merger
Planned takeover will decrease competition, leading to higher costs and fewer options for farmers
-
BusinessBrexit raises regulatory worries
Risk of doubling legal burden for industry undermines referendum’s ‘red-tape cutting’ claims
-
OpinionBuilding business across borders
Internationality is here to stay. Companies need to capitalise on it
-
BusinessEU conditionally approves Dow–DuPont merger
To satisfy competition concerns, DuPont will swap crop protection R&D assets for FMC’s nutrition business
-
BusinessEU recommends withdrawing drugs approved on unreliable data
Indian firm Micro Therapeutic Research Labs accused of misrepresenting clinical data and documentation deficiencies
-
OpinionSafety first with gene editing
Why Darpa is creating a biosafety and biosecurity toolkit for genome editors
-
BusinessIndustry weighs in on Nafta rewrite
Canadian, Mexican and US trade bodies united in call for more unified regulation in new trade deal
-
OpinionHow much is your chief executive worth?
The executive pay and equality debate is here to stay
-
OpinionDrug regulation is a burden worth bearing
Calls to break down regulatory barriers show a misunderstanding of the industry
-
NewsTrump’s health secretary faces conflict of interest allegations
Tom Price accused of abusing his office to favour companies in which he invested
-
NewsBPA added to ‘very high concern’ list of substances in EU
Decision by the European Chemicals Agency could ultimately lead to a ban on the chemical’s use